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LETTER TO THE EDITOR
Successful renal transplant in patient with controlled
pulmonary non-tuberculous mycobacterium infection
P
atients with Kidney transplants are known to be
at increased risk of non-tuberculous mycobacterial
infections (13). This can take the form of skin
infection, lung infection and more seriously disseminated
disease. The increased risk is related to the reduced cel-
lular immunity due to immune suppressant drugs. Very
little is known about the risk of Kidney transplantation in
patients who are already known to have Non-tuberculous
mycobacterial infection.
A 55-year-old female known with CKD5 on haemodia-
lysis secondary to Anti-Glomerular Basement Membrane
(anti-GBM) disease was referred to the chest clinic because
of an incidental finding of a small cavitation lesion at the
right upper lung zone. At the time, she had no symptoms
related to her chest although she did have history of
chest infection in the past. Computerised Tomography
(CT) scan demonstrated scattered bronchocentric nodules
in the upper lobes with some areas of cavitation (Fig. 1).
Bronchoscopic bronchial lavage was smear positive for
acid fast bacilli and culture grew Mycobacterium avium
complex (MAC).
A diagnosis of pulmonary infection with MAC was
made, and she was started on a treatment regimen of
a combination of clarithromycin 500 mg twice daily,
rifampicin 600 mg once daily, and ethambutol 1,300 mg
three times a week to be taken in the evening preceding
the dialysis day. This was based on 55 kg dry weight.
We planned to give her a course of 2 years. However,
she was very keen to proceed with live donor renal
transplant. Consultation of the literature did not give
any clinical guidance to manage such a situation. After
consultation with international experts in the UK and US,
we decided to monitor her response to treatment, and
if her condition was controlled, we decided to proceed
with transplantation after 9 months of therapy. During
the following 9 months of treatment, her chest remained
stable and she had no respiratory symptoms, and she
remained very keen to proceed with the renal transplant
after detailed discussions about risk benefit. A repeat
CT chest showed improvement in some pulmonary opa-
cities while others remained unchanged. There was no
evidence of new lesions.
Based on stability of her condition and reassuring CT
scan, she proceeded with live donor renal transplant.
Immune suppression was given with tacrolimus 5 mg AM
and 6 mg PM and mycophenolate 540 mg bd while MAC
infection treatment was continued on the same regimen.
She remained under monitoring and follow-up both
clinically and radiologically (chest X rays) at the Myco-
bacterial Infections Clinic. Her chest remained stable and
asymptomatic, she reported no sputum production, and
so culture for mycobacteria was not repeated. She
completed a 2 years course of treatment following which
we continued to monitor her with no sign of relapse.
Conclusion
We believe that this is the first case of renal transplant in a
patient already known with MAC pulmonary infection
controlled with treatment. The timing of transplant was
difficult. She was very keen to progress with the trans-
plant as early as possible. Obviously it was not possible
to progress with transplant until we were confident that
her disease was well controlled on treatment. Six to nine
months of effective treatment seemed reasonable but was
not based on concrete evidence. We felt it is important to
share this experience with colleagues interested in this field.
Patient consent
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Fig. 1. CT chest showing multiple nodular lesions with
cavitation.
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